Akr1c3 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of AKR1C3 mRNA | CTD | PMID:22079256 |
Akr1c3 | Rat | (20S)-20-hydroxypregn-4-en-3-one | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein results in increased metabolism of Progesterone] which results in increased chemical synthesis of 20-alpha-Dihydroprogesterone and [AKR1C3 protein results in increased reduction of Progesterone] which results in increased chemical synthesis of 20-alpha-Dihydroprogesterone | CTD | PMID:19010312 and PMID:20036328 |
Akr1c3 | Rat | (20S)-20-hydroxypregn-4-en-3-one | increases chemical synthesis | EXP | | 6480464 | AKR1C18 protein results in increased chemical synthesis of 20-alpha-Dihydroprogesterone | CTD | PMID:8172618 |
Akr1c3 | Rat | (20S)-20-hydroxypregn-4-en-3-one | increases chemical synthesis | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased chemical synthesis of 20-alpha-Dihydroprogesterone | CTD | PMID:25463305 |
Akr1c3 | Rat | (E)-cinnamyl alcohol | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | cinnamyl alcohol results in increased expression of AKR1C3 mRNA | CTD | PMID:20566472 |
Akr1c3 | Rat | (S)-naringenin | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | naringenin results in decreased activity of AKR1C3 protein | CTD | PMID:19007764 |
Akr1c3 | Rat | 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | multiple interactions | EXP | | 6480464 | 2 more ... | CTD | PMID:19414516 |
Akr1c3 | Rat | 1,10-phenanthroline | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | 1 and 10-phenanthroline results in decreased activity of AKR1C3 protein | CTD | PMID:12604236 |
Akr1c3 | Rat | 1,2-dichloroethane | increases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of AKR1C18 mRNA | CTD | PMID:28960355 |
Akr1c3 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of AKR1C18 mRNA | CTD | PMID:22206623 |
Akr1c3 | Rat | 1,8-Dinitropyrene | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein results in increased degradation of 1 and 8-dinitropyrene] which results in increased abundance of 1-amino-8-nitropyrene | CTD | PMID:36399404 |
Akr1c3 | Rat | 1-Aminopyrene | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein results in increased degradation of 1-nitropyrene] which results in increased abundance of 1-aminopyrene | CTD | PMID:36399404 |
Akr1c3 | Rat | 1-chloro-2,4-dinitrobenzene | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Dinitrochlorobenzene results in increased expression of AKR1C3 mRNA | CTD | PMID:20566472 |
Akr1c3 | Rat | 1-chloro-2,4-dinitrobenzene | affects expression | ISO | Akr1c18 (Mus musculus) | 6480464 | Dinitrochlorobenzene affects the expression of AKR1C18 mRNA | CTD | PMID:22302311 |
Akr1c3 | Rat | 1-naphthyl isothiocyanate | decreases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of AKR1C3 mRNA | CTD | PMID:25380136 and PMID:30723492 |
Akr1c3 | Rat | 1-nitropyrene | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein results in increased degradation of 1-nitropyrene] which results in increased abundance of 1-aminopyrene | CTD | PMID:36399404 |
Akr1c3 | Rat | 11-deoxycorticosterone | increases metabolic processing | ISO | Akr1c18 (Mus musculus) | 6480464 | AKR1C18 protein results in increased metabolism of Desoxycorticosterone | CTD | PMID:17122075 |
Akr1c3 | Rat | 13-dihydrodaunorubicin | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein results in increased metabolism of Daunorubicin] which results in increased abundance of daunorubicinol more ... | CTD | PMID:30703376 more ... |
Akr1c3 | Rat | 13-dihydrodaunorubicin | increases chemical synthesis | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased chemical synthesis of daunorubicinol | CTD | PMID:33025066 |
Akr1c3 | Rat | 15-deoxy-Delta(12,14)-prostaglandin J2 | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [Medroxyprogesterone Acetate inhibits the reaction [[AKR1C3 protein results in increased metabolism of Prostaglandin D2] which results in increased abundance of Dinoprost]] which results in increased abundance of 15-deoxy-delta(12 and 14)-prostaglandin J2 | CTD | PMID:19997560 |
Akr1c3 | Rat | 17beta-estradiol | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein results in increased metabolism of Estrone] which results in increased chemical synthesis of Estradiol more ... | CTD | PMID:19010312 more ... |
Akr1c3 | Rat | 17beta-estradiol | decreases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | Estradiol results in decreased expression of AKR1C18 mRNA | CTD | PMID:39298647 |
Akr1c3 | Rat | 17beta-estradiol | increases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | Estradiol results in increased expression of AKR1C18 mRNA | CTD | PMID:19484750 |
Akr1c3 | Rat | 17beta-estradiol | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of AKR1C3 mRNA | CTD | PMID:19619570 more ... |
Akr1c3 | Rat | 17beta-hydroxy-5alpha-androstan-3-one | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein results in increased metabolism of Androstenedione] which results in increased chemical synthesis of Dihydrotestosterone and Flufenamic Acid inhibits the reaction [AKR1C3 protein results in increased metabolism of Dihydrotestosterone] | CTD | PMID:14672942 and PMID:19010312 |
Akr1c3 | Rat | 17beta-hydroxy-5alpha-androstan-3-one | increases metabolic processing | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased metabolism of Dihydrotestosterone | CTD | PMID:14672942 |
Akr1c3 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:38568856 |
Akr1c3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of AKR1C3 mRNA | CTD | PMID:19619570 |
Akr1c3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of AKR1C18 mRNA | CTD | PMID:28922406 |
Akr1c3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Akr1c18 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of AKR1C18 mRNA | CTD | PMID:21570461 |
Akr1c3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of AKR1C3 mRNA | CTD | PMID:21215274 |
Akr1c3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of AKR1C3 mRNA] | CTD | PMID:21215274 |
Akr1c3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of AKR1C3 mRNA | CTD | PMID:19619570 |
Akr1c3 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Akr1c18 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:38648751 |
Akr1c3 | Rat | 2-amino-14,16-dimethyloctadecan-3-ol | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | 2-amino-14 and 16-dimethyloctadecan-3-ol results in decreased expression of AKR1C3 protein | CTD | PMID:32044396 |
Akr1c3 | Rat | 2-hydroxyethyl methacrylate | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | hydroxyethyl methacrylate results in increased expression of AKR1C3 mRNA | CTD | PMID:30497689 |
Akr1c3 | Rat | 2-hydroxypropanoic acid | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of AKR1C3 mRNA | CTD | PMID:20566472 |
Akr1c3 | Rat | 2-methoxyethanol | multiple interactions | EXP | | 6480464 | methyl cellosolve inhibits the reaction [Bromocriptine results in increased expression of AKR1C3 mRNA] | CTD | PMID:21427058 |
Akr1c3 | Rat | 2-methoxyethanol | decreases expression | EXP | | 6480464 | methyl cellosolve results in decreased expression of AKR1C3 mRNA | CTD | PMID:21427058 |
Akr1c3 | Rat | 20-hydroxypregn-4-en-3-one | increases chemical synthesis | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased chemical synthesis of 3-hydroxypregn-4-en-20-one | CTD | PMID:25463305 |
Akr1c3 | Rat | 3,3',5-triiodo-L-thyronine | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Triiodothyronine results in increased expression of AKR1C3 mRNA | CTD | PMID:15507505 |
Akr1c3 | Rat | 3,4-dichloroaniline | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | 3 and 4-dichloroaniline results in increased expression of AKR1C3 mRNA | CTD | PMID:24172598 |
Akr1c3 | Rat | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of AKR1C18 mRNA | CTD | PMID:20188158 |
Akr1c3 | Rat | 3-chloropropane-1,2-diol | decreases expression | EXP | | 6480464 | alpha-Chlorohydrin results in decreased expression of AKR1C3 protein | CTD | PMID:34915118 |
Akr1c3 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of AKR1C3 mRNA | CTD | PMID:28628672 |
Akr1c3 | Rat | 3-Nitrobenzanthrone | increases reduction | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased reduction of 3-nitrobenzanthrone | CTD | PMID:30406992 |
Akr1c3 | Rat | 3-Nitrobenzanthrone | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein results in increased reduction of 3-nitrobenzanthrone] which results in increased chemical synthesis of 3-aminobenzanthrone and [AKR1C3 protein results in increased reduction of 3-nitrobenzanthrone] which results in increased chemical synthesis of N-hydroxy-3-aminobenzanthrone | CTD | PMID:30406992 |
Akr1c3 | Rat | 3alpha-hydroxy-5beta-pregnan-20-one | increases chemical synthesis | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased chemical synthesis of Pregnanolone | CTD | PMID:25463305 |
Akr1c3 | Rat | 4,4'-diaminodiphenylmethane | decreases expression | EXP | | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of AKR1C3 mRNA | CTD | PMID:25380136 |
Akr1c3 | Rat | 4,4'-diaminodiphenylmethane | increases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of AKR1C18 mRNA | CTD | PMID:18648102 |
Akr1c3 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | bisphenol S results in decreased expression of AKR1C3 mRNA | CTD | PMID:38568856 |
Akr1c3 | Rat | 4-hydroxybenzoic acid | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | 4-hydroxybenzoic acid analog results in decreased activity of AKR1C3 protein | CTD | PMID:27163852 |
Akr1c3 | Rat | 4-hydroxynon-2-enal | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | 7-hydroxycoumarin inhibits the reaction [AKR1C3 mutant form results in increased susceptibility to 4-hydroxy-2-nonenal] | CTD | PMID:22964423 |
Akr1c3 | Rat | 4-hydroxynon-2-enal | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | 4-hydroxy-2-nonenal results in increased expression of AKR1C3 mRNA and 4-hydroxy-2-nonenal results in increased expression of AKR1C3 protein | CTD | PMID:22964423 and PMID:30849339 |
Akr1c3 | Rat | 4-hydroxynon-2-enal | increases response to substance | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 mutant form results in increased susceptibility to 4-hydroxy-2-nonenal | CTD | PMID:22964423 |
Akr1c3 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of AKR1C3 mRNA | CTD | PMID:28973697 |
Akr1c3 | Rat | 5-fluorouracil | affects expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Fluorouracil affects the expression of AKR1C3 mRNA | CTD | PMID:16584549 |
Akr1c3 | Rat | 5-fluorouracil | affects response to substance | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein affects the susceptibility to Fluorouracil | CTD | PMID:16217747 |
Akr1c3 | Rat | 5alpha-Pregnan-20alpha-ol-3-one | increases chemical synthesis | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased chemical synthesis of allopregnan-20 alpha-ol-3-one | CTD | PMID:25463305 |
Akr1c3 | Rat | 5alpha-pregnane-3,20-dione | increases chemical synthesis | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased chemical synthesis of 5-alpha-Dihydroprogesterone | CTD | PMID:25463305 |
Akr1c3 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of AKR1C18 mRNA | CTD | PMID:24780913 |
Akr1c3 | Rat | 7-hydroxyflavone | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | 7-hydroxyflavone results in decreased activity of AKR1C3 protein | CTD | PMID:19007764 |
Akr1c3 | Rat | 9,10-phenanthroquinone | increases metabolic processing | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased metabolism of 9 and 10-phenanthrenequinone | CTD | PMID:17950253 and PMID:29108775 |
Akr1c3 | Rat | 9,10-phenanthroquinone | increases reduction | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased reduction of 9 and 10-phenanthrenequinone | CTD | PMID:19442656 more ... |
Akr1c3 | Rat | 9,10-phenanthroquinone | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | 9 and 10-phenanthrenequinone results in increased expression of AKR1C3 protein | CTD | PMID:29108775 |
Akr1c3 | Rat | 9,10-phenanthroquinone | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein results in increased reduction of 9 more ... | CTD | PMID:17950253 more ... |
Akr1c3 | Rat | 9-cis-retinal | increases reduction | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein mutant form results in increased reduction of 9-cis-retinal and AKR1C3 protein results in increased reduction of 9-cis-retinal | CTD | PMID:21851338 |
Akr1c3 | Rat | acetylsalicylic acid | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Aspirin results in decreased activity of AKR1C3 protein | CTD | PMID:19010312 |
Akr1c3 | Rat | acrolein | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AKR1C3 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AKR1C3 mRNA | CTD | PMID:32699268 |
Akr1c3 | Rat | actinomycin D | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of AKR1C3 protein | CTD | PMID:38460933 |
Akr1c3 | Rat | aldehydo-D-glucose | multiple interactions | ISO | Akr1c18 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of AKR1C18 mRNA | CTD | PMID:37567420 |
Akr1c3 | Rat | all-trans-retinal | increases reduction | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased reduction of Retinaldehyde | CTD | PMID:23261716 |
Akr1c3 | Rat | all-trans-retinoic acid | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of AKR1C3 mRNA | CTD | PMID:23724009 and PMID:33167477 |
Akr1c3 | Rat | all-trans-retinoic acid | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [Tretinoin results in decreased activity of AKR1C3 protein] which results in increased susceptibility to Daunorubicin more ... | CTD | PMID:32588086 |
Akr1c3 | Rat | Aloe emodin | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | aloe emodin results in decreased activity of AKR1C3 protein | CTD | PMID:35065925 |
Akr1c3 | Rat | alpha-hexylcinnamaldehyde | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | hexyl cinnamic aldehyde results in increased expression of AKR1C3 mRNA | CTD | PMID:20566472 |
Akr1c3 | Rat | alpha-hexylcinnamaldehyde | affects expression | ISO | Akr1c18 (Mus musculus) | 6480464 | hexyl cinnamic aldehyde affects the expression of AKR1C18 mRNA | CTD | PMID:22302311 |
Akr1c3 | Rat | alpha-pinene | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AKR1C3 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AKR1C3 mRNA | CTD | PMID:32699268 |
Akr1c3 | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of AKR1C3 mRNA | CTD | PMID:35163327 |
Akr1c3 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of AKR1C18 mRNA | CTD | PMID:16483693 |
Akr1c3 | Rat | androst-4-ene-3,17-dione | increases metabolic processing | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased metabolism of Androstenedione | CTD | PMID:19010312 |
Akr1c3 | Rat | androst-4-ene-3,17-dione | increases reduction | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased reduction of Androstenedione | CTD | PMID:17950253 and PMID:20036328 |
Akr1c3 | Rat | androst-4-ene-3,17-dione | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein results in increased metabolism of Androstenedione] which results in increased chemical synthesis of Dihydrotestosterone more ... | CTD | PMID:17950253 more ... |
Akr1c3 | Rat | antimonite | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of AKR1C3 mRNA | CTD | PMID:32076005 |
Akr1c3 | Rat | antirheumatic drug | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of AKR1C3 mRNA | CTD | PMID:24449571 |
Akr1c3 | Rat | arsane | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of AKR1C3 mRNA | CTD | PMID:32525701 |
Akr1c3 | Rat | arsane | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Arsenic results in increased expression of AKR1C3 mRNA | CTD | PMID:36861143 |
Akr1c3 | Rat | arsenic atom | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of AKR1C3 mRNA | CTD | PMID:32525701 |
Akr1c3 | Rat | arsenic atom | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Arsenic results in increased expression of AKR1C3 mRNA | CTD | PMID:36861143 |
Akr1c3 | Rat | arsenite(3-) | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of arsenite] which results in increased expression of AKR1C3 mRNA | CTD | PMID:32076005 |
Akr1c3 | Rat | arsenous acid | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to AKR1C3 protein] | CTD | PMID:26598702 |
Akr1c3 | Rat | arsenous acid | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of AKR1C3 mRNA | CTD | PMID:19128835 more ... |
Akr1c3 | Rat | arsenous acid | decreases response to substance | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 |
Akr1c3 | Rat | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of AKR1C3 mRNA | CTD | PMID:21427058 |
Akr1c3 | Rat | avobenzone | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | avobenzone results in increased expression of AKR1C3 mRNA | CTD | PMID:31016361 |
Akr1c3 | Rat | Azoxymethane | multiple interactions | ISO | Akr1c18 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of AKR1C18 mRNA | CTD | PMID:29950665 |
Akr1c3 | Rat | Bandrowski's base | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Bandrowski's base results in increased expression of AKR1C3 mRNA | CTD | PMID:20566472 |
Akr1c3 | Rat | benzbromarone | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Benzbromarone results in decreased activity of AKR1C3 protein | CTD | PMID:12604236 |
Akr1c3 | Rat | benzo[a]pyrene | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [Butyric Acid co-treated with Benzo(a)pyrene] results in increased expression of AKR1C3 mRNA more ... | CTD | PMID:17612574 and PMID:30439556 |
Akr1c3 | Rat | benzo[a]pyrene | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of AKR1C3 mRNA | CTD | PMID:30439556 |
Akr1c3 | Rat | benzo[a]pyrene | decreases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of AKR1C18 mRNA | CTD | PMID:22228805 |
Akr1c3 | Rat | benzo[a]pyrene | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of AKR1C3 mRNA and Benzo(a)pyrene results in increased expression of AKR1C3 protein | CTD | PMID:20106945 more ... |
Akr1c3 | Rat | Benzo[a]pyrene-7,8-diol | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein co-treated with NADP] results in increased oxidation of and affects the activity of benzo(a)pyrene 7 and 8-dihydrodiol | CTD | PMID:21910479 |
Akr1c3 | Rat | benzo[a]pyrene-7,8-dione | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein co-treated with NADP] results in increased reduction of and affects the activity of benzo(a)pyrene-7 and 8-dione | CTD | PMID:21910479 |
Akr1c3 | Rat | benzo[e]pyrene | increases methylation | ISO | AKR1C3 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of AKR1C3 intron | CTD | PMID:30157460 |
Akr1c3 | Rat | benzoic acid | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Benzoic Acid results in increased expression of AKR1C3 mRNA | CTD | PMID:20566472 |
Akr1c3 | Rat | beta-lapachone | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of AKR1C3 mRNA | CTD | PMID:38218311 |
Akr1c3 | Rat | beta-naphthoflavone | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | beta-Naphthoflavone results in increased expression of AKR1C3 mRNA | CTD | PMID:19737606 and PMID:32151702 |
Akr1c3 | Rat | beta-naphthoflavone | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of AKR1C18 mRNA | CTD | PMID:18164116 |
Akr1c3 | Rat | bexarotene | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | bexarotene results in increased expression of AKR1C3 mRNA | CTD | PMID:17178900 |
Akr1c3 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of AKR1C3 mRNA and bisphenol A results in decreased expression of AKR1C4 mRNA | CTD | PMID:25181051 |
Akr1c3 | Rat | bisphenol A | increases methylation | ISO | AKR1C3 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of AKR1C3 gene | CTD | PMID:31601247 |
Akr1c3 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of AKR1C3 mRNA | CTD | PMID:32145629 |
Akr1c3 | Rat | bisphenol A | affects expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | bisphenol A affects the expression of AKR1C3 mRNA | CTD | PMID:30903817 |
Akr1c3 | Rat | bisphenol AF | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | bisphenol AF results in increased expression of AKR1C3 protein | CTD | PMID:34186270 |
Akr1c3 | Rat | Bisphenol B | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of AKR1C3 protein | CTD | PMID:34186270 |
Akr1c3 | Rat | bisphenol F | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | bisphenol F results in increased expression of AKR1C3 protein | CTD | PMID:34186270 |
Akr1c3 | Rat | bortezomib | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Bortezomib results in increased expression of AKR1C3 mRNA | CTD | PMID:21215737 |
Akr1c3 | Rat | Bromazepam | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Bromazepam results in decreased activity of AKR1C3 protein | CTD | PMID:11995921 |
Akr1c3 | Rat | bromocriptine | increases expression | EXP | | 6480464 | Bromocriptine results in increased expression of AKR1C3 mRNA | CTD | PMID:21427058 |
Akr1c3 | Rat | bromocriptine | multiple interactions | EXP | | 6480464 | methyl cellosolve inhibits the reaction [Bromocriptine results in increased expression of AKR1C3 mRNA] | CTD | PMID:21427058 |
Akr1c3 | Rat | butan-1-ol | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of AKR1C3 mRNA | CTD | PMID:29432896 |
Akr1c3 | Rat | butyric acid | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Butyric Acid results in increased expression of AKR1C3 mRNA | CTD | PMID:30439556 |
Akr1c3 | Rat | butyric acid | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [Butyric Acid co-treated with Benzo(a)pyrene] results in increased expression of AKR1C3 mRNA more ... | CTD | PMID:30439556 |
Akr1c3 | Rat | cadmium acetate | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | cadmium acetate results in increased expression of AKR1C3 mRNA and cadmium acetate results in increased expression of AKR1C3 protein | CTD | PMID:21787718 |
Akr1c3 | Rat | cadmium acetate | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cadmium acetate results in increased expression of AKR1C3 protein] more ... | CTD | PMID:21787718 |
Akr1c3 | Rat | cadmium atom | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Cadmium results in increased expression of AKR1C3 mRNA | CTD | PMID:21120746 |
Akr1c3 | Rat | cadmium atom | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AKR1C3 mRNA | CTD | PMID:29741670 more ... |
Akr1c3 | Rat | cadmium atom | decreases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | Cadmium results in decreased expression of AKR1C18 mRNA | CTD | PMID:24067728 |
Akr1c3 | Rat | cadmium dichloride | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AKR1C3 mRNA | CTD | PMID:29741670 more ... |
Akr1c3 | Rat | cadmium dichloride | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of AKR1C3 mRNA | CTD | PMID:38568856 |
Akr1c3 | Rat | capecitabine | increases response to substance | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased susceptibility to Capecitabine | CTD | PMID:16734730 |
Akr1c3 | Rat | carbamazepine | affects expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of AKR1C3 mRNA | CTD | PMID:25979313 |
Akr1c3 | Rat | carbon nanotube | decreases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of AKR1C18 mRNA | CTD | PMID:25620056 |
Akr1c3 | Rat | CGP 52608 | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to AKR1C3 gene] | CTD | PMID:28238834 |
Akr1c3 | Rat | cholic acid | increases abundance | EXP | | 6480464 | AKR1C4 protein results in increased abundance of Cholic Acid | CTD | PMID:3468121 |
Akr1c3 | Rat | choline | multiple interactions | ISO | Akr1c18 (Mus musculus) | 6480464 | [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of AKR1C18 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of AKR1C18 mRNA | CTD | PMID:20938992 and PMID:29127188 |
Akr1c3 | Rat | chromium(6+) | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of AKR1C3 mRNA | CTD | PMID:38479592 |
Akr1c3 | Rat | cinnamyl alcohol | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | cinnamyl alcohol results in increased expression of AKR1C3 mRNA | CTD | PMID:20566472 |
Akr1c3 | Rat | cisplatin | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of AKR1C3 mRNA and Cisplatin results in increased expression of AKR1C3 protein | CTD | PMID:23165153 and PMID:27392435 |
Akr1c3 | Rat | cisplatin | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of AKR1C3 mRNA more ... | CTD | PMID:23165153 and PMID:27392435 |
Akr1c3 | Rat | cisplatin | decreases response to substance | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in decreased susceptibility to Cisplatin | CTD | PMID:23165153 |
Akr1c3 | Rat | Clofop | increases reduction | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased reduction of fenofibric acid | CTD | PMID:27599626 |
Akr1c3 | Rat | cloxazolam | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | cloxazolam results in decreased activity of AKR1C3 protein | CTD | PMID:11995921 and PMID:12604236 |
Akr1c3 | Rat | cobalt dichloride | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of AKR1C3 mRNA | CTD | PMID:17553155 |
Akr1c3 | Rat | colforsin daropate hydrochloride | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Colforsin results in decreased expression of AKR1C3 mRNA | CTD | PMID:28235592 |
Akr1c3 | Rat | coniferyl aldehyde | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | coniferaldehyde results in increased expression of AKR1C3 mRNA | CTD | PMID:26275128 |
Akr1c3 | Rat | copper atom | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of AKR1C3 mRNA | CTD | PMID:20971185 |
Akr1c3 | Rat | copper(0) | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of AKR1C3 mRNA | CTD | PMID:20971185 |
Akr1c3 | Rat | copper(II) chloride | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | cupric chloride results in increased expression of AKR1C3 mRNA | CTD | PMID:38568856 |
Akr1c3 | Rat | copper(II) sulfate | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of AKR1C3 mRNA | CTD | PMID:19549813 |
Akr1c3 | Rat | crotonaldehyde | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | 2-butenal results in increased expression of AKR1C3 mRNA | CTD | PMID:20471460 |
Akr1c3 | Rat | cycloheximide | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | Cycloheximide inhibits the reaction [cadmium acetate results in increased expression of AKR1C3 protein] | CTD | PMID:21787718 |
Akr1c3 | Rat | cyclopentanol | increases oxidation | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased oxidation of cyclopentanol | CTD | PMID:23261716 |
Akr1c3 | Rat | cyclopentanone | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein co-treated with NADP] results in increased reduction of cyclopentanone more ... | CTD | PMID:23261716 |
Akr1c3 | Rat | cyclopentanone | increases reduction | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased reduction of cyclopentanone | CTD | PMID:23261716 |
Akr1c3 | Rat | cyclosporin A | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of AKR1C3 mRNA | CTD | PMID:25562108 and PMID:33631201 |
Akr1c3 | Rat | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of AKR1C18 mRNA | CTD | PMID:21865292 |
Akr1c3 | Rat | D-glucose | multiple interactions | ISO | Akr1c18 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of AKR1C18 mRNA | CTD | PMID:37567420 |
Akr1c3 | Rat | daunorubicin | increases metabolic processing | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased metabolism of Daunorubicin and AKR1C3 results in increased metabolism of Daunorubicin | CTD | PMID:20837989 more ... |
Akr1c3 | Rat | daunorubicin | increases reduction | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased reduction of Daunorubicin | CTD | PMID:33025066 and PMID:35972551 |
Akr1c3 | Rat | daunorubicin | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein results in increased metabolism of Daunorubicin] which results in increased abundance of daunorubicinol more ... | CTD | PMID:29992508 more ... |
Akr1c3 | Rat | daunorubicin | decreases response to substance | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in decreased susceptibility to Daunorubicin | CTD | PMID:29992508 more ... |
Akr1c3 | Rat | DDE | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of AKR1C3 mRNA | CTD | PMID:38568856 |
Akr1c3 | Rat | deguelin | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | deguelin results in increased expression of AKR1C3 mRNA | CTD | PMID:33512557 |
Akr1c3 | Rat | dehydroepiandrosterone | affects metabolic processing | EXP | | 6480464 | AKR1C18 protein affects the metabolism of Dehydroepiandrosterone | CTD | PMID:15261307 |
Akr1c3 | Rat | desogestrel | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Desogestrel results in decreased activity of AKR1C3 protein | CTD | PMID:21182831 |
Akr1c3 | Rat | dexamethasone | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Dexamethasone results in increased expression of AKR1C3 mRNA | CTD | PMID:25047013 |
Akr1c3 | Rat | dexamethasone | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of AKR1C3 mRNA | CTD | PMID:28628672 |
Akr1c3 | Rat | dextran sulfate | multiple interactions | ISO | Akr1c18 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of AKR1C18 mRNA | CTD | PMID:29950665 |
Akr1c3 | Rat | diarsenic trioxide | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to AKR1C3 protein] | CTD | PMID:26598702 |
Akr1c3 | Rat | diarsenic trioxide | decreases response to substance | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 |
Akr1c3 | Rat | diarsenic trioxide | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of AKR1C3 mRNA | CTD | PMID:19128835 more ... |
Akr1c3 | Rat | diazepam | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Diazepam results in decreased activity of AKR1C3 protein | CTD | PMID:11995921 and PMID:12604236 |
Akr1c3 | Rat | dibenzo[a,l]pyrene | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [Particulate Matter co-treated with dibenzo(a more ... | CTD | PMID:17612574 |
Akr1c3 | Rat | Dibutyl phosphate | affects expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of AKR1C3 mRNA | CTD | PMID:37042841 |
Akr1c3 | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of AKR1C18 mRNA | CTD | PMID:21266533 |
Akr1c3 | Rat | dicrotophos | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of AKR1C3 mRNA | CTD | PMID:28302478 |
Akr1c3 | Rat | diethylstilbestrol | increases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | Diethylstilbestrol results in increased expression of AKR1C3 mRNA | CTD | PMID:19665456 |
Akr1c3 | Rat | diethylstilbestrol | multiple interactions | ISO | Akr1c18 (Mus musculus) | 6480464 | sodium arsenite promotes the reaction [Diethylstilbestrol results in increased expression of AKR1C3 mRNA] | CTD | PMID:19665456 |
Akr1c3 | Rat | dinaciclib | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | dinaciclib binds to and results in decreased activity of AKR1C3 protein and dinaciclib inhibits the reaction [AKR1C3 protein results in decreased susceptibility to Daunorubicin] | CTD | PMID:29992508 |
Akr1c3 | Rat | dioxygen | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein results in increased reduction of and affects the activity of benzo(a)pyrene-3 and 6-quinone] which results in decreased abundance of Oxygen | CTD | PMID:21910479 |
Akr1c3 | Rat | dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Antimony Potassium Tartrate results in increased expression of AKR1C3 mRNA and Antimony Potassium Tartrate results in increased expression of AKR1C3 protein | CTD | PMID:28713220 |
Akr1c3 | Rat | dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of AKR1C3 mRNA | CTD | PMID:32076005 |
Akr1c3 | Rat | disulfiram | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Disulfiram results in increased expression of AKR1C3 mRNA | CTD | PMID:20566472 |
Akr1c3 | Rat | diuron | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Diuron metabolite results in increased expression of AKR1C3 mRNA | CTD | PMID:24172598 |
Akr1c3 | Rat | dorsomorphin | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 |
Akr1c3 | Rat | doxifluridine | increases response to substance | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased susceptibility to doxifluridine | CTD | PMID:16734730 |
Akr1c3 | Rat | doxorubicin | affects reduction | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein affects the reduction of Doxorubicin | CTD | PMID:18635746 |
Akr1c3 | Rat | doxorubicin | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of AKR1C3 mRNA | CTD | PMID:29803840 |
Akr1c3 | Rat | doxorubicin | increases metabolic processing | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 results in increased metabolism of Doxorubicin | CTD | PMID:20837989 |
Akr1c3 | Rat | dutasteride | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Dutasteride results in increased expression of AKR1C3 mRNA | CTD | PMID:16806904 |
Akr1c3 | Rat | dydrogesterone | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Dydrogesterone results in decreased activity of AKR1C3 protein | CTD | PMID:21182831 |
Akr1c3 | Rat | dydrogesterone | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Dydrogesterone results in decreased expression of AKR1C3 mRNA | CTD | PMID:23183084 |
Akr1c3 | Rat | emodin | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Emodin results in decreased activity of AKR1C3 protein | CTD | PMID:35065925 |
Akr1c3 | Rat | enasidenib | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | enasidenib inhibits the reaction [[AKR1C3 protein results in increased reduction of Daunorubicin] which results in increased abundance of daunorubicinol] more ... | CTD | PMID:35972551 |
Akr1c3 | Rat | enasidenib | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | enasidenib results in decreased activity of AKR1C3 protein | CTD | PMID:35972551 |
Akr1c3 | Rat | estazolam | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Estazolam results in decreased activity of AKR1C3 protein | CTD | PMID:11995921 |
Akr1c3 | Rat | estrone | increases metabolic processing | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased metabolism of Estrone | CTD | PMID:19010312 |
Akr1c3 | Rat | estrone | increases reduction | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased reduction of Estrone | CTD | PMID:20036328 |
Akr1c3 | Rat | estrone | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein results in increased metabolism of Estrone] which results in increased chemical synthesis of Estradiol and [AKR1C3 protein results in increased reduction of Estrone] which results in increased chemical synthesis of Estradiol | CTD | PMID:19010312 and PMID:20036328 |
Akr1c3 | Rat | ethanol | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of AKR1C3 mRNA | CTD | PMID:29432896 |
Akr1c3 | Rat | ethylparaben | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | ethyl-p-hydroxybenzoate results in increased expression of AKR1C3 mRNA | CTD | PMID:37690743 |
Akr1c3 | Rat | eugenol | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Eugenol results in increased expression of AKR1C3 mRNA | CTD | PMID:20566472 |
Akr1c3 | Rat | farnesal | increases reduction | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased reduction of farnesal | CTD | PMID:21187079 |
Akr1c3 | Rat | farnesoic acid | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [Flurbiprofen results in decreased activity of AKR1C3 protein] which results in increased chemical synthesis of farnesoic acid and [tolfenamic acid results in decreased activity of AKR1C3 protein] which results in increased chemical synthesis of farnesoic acid | CTD | PMID:21187079 |
Akr1c3 | Rat | farnesol | increases chemical synthesis | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased chemical synthesis of Farnesol | CTD | PMID:21187079 |
Akr1c3 | Rat | farnesol | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [Flurbiprofen results in decreased activity of AKR1C3 protein] which results in increased metabolism of Farnesol and [tolfenamic acid results in decreased activity of AKR1C3 protein] which results in increased metabolism of Farnesol | CTD | PMID:21187079 |
Akr1c3 | Rat | fenamic acid | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | fenamic acid analog results in decreased activity of AKR1C3 protein | CTD | PMID:19010312 |
Akr1c3 | Rat | flufenamic acid | affects binding | ISO | AKR1C3 (Homo sapiens) | 6480464 | Flufenamic Acid binds to AKR1C3 protein | CTD | PMID:14996743 |
Akr1c3 | Rat | flufenamic acid | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | Flufenamic Acid inhibits the reaction [AKR1C3 protein affects the susceptibility to oxaliplatin] and Flufenamic Acid inhibits the reaction [AKR1C3 protein results in increased metabolism of Dihydrotestosterone] | CTD | PMID:14672942 and PMID:23933386 |
Akr1c3 | Rat | flufenamic acid | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Flufenamic Acid results in decreased activity of AKR1C3 protein | CTD | PMID:12604236 |
Akr1c3 | Rat | flunitrazepam | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Flunitrazepam results in decreased activity of AKR1C3 protein | CTD | PMID:11995921 |
Akr1c3 | Rat | flurbiprofen | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [Flurbiprofen results in decreased activity of AKR1C3 protein] which results in increased chemical synthesis of farnesoic acid and [Flurbiprofen results in decreased activity of AKR1C3 protein] which results in increased metabolism of Farnesol | CTD | PMID:21187079 |
Akr1c3 | Rat | flurbiprofen | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Flurbiprofen results in decreased activity of AKR1C3 protein | CTD | PMID:19010312 and PMID:21187079 |
Akr1c3 | Rat | folic acid | multiple interactions | ISO | Akr1c18 (Mus musculus) | 6480464 | [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of AKR1C18 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of AKR1C18 mRNA | CTD | PMID:20938992 and PMID:29127188 |
Akr1c3 | Rat | formaldehyde | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of AKR1C3 mRNA | CTD | PMID:23649840 |
Akr1c3 | Rat | formaldehyde | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of AKR1C3 mRNA | CTD | PMID:28937961 |
Akr1c3 | Rat | Frangulin A | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | frangulin A results in decreased activity of AKR1C3 protein | CTD | PMID:35065925 |
Akr1c3 | Rat | Frangulin B | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | frangulin B results in decreased activity of AKR1C3 protein | CTD | PMID:35065925 |
Akr1c3 | Rat | fructose | multiple interactions | ISO | Akr1c18 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of AKR1C18 mRNA | CTD | PMID:37567420 |
Akr1c3 | Rat | furan | increases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | furan results in increased expression of AKR1C18 mRNA | CTD | PMID:24183702 and PMID:37517673 |
Akr1c3 | Rat | geranylgeraniol | increases chemical synthesis | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased chemical synthesis of geranylgeraniol | CTD | PMID:21187079 |
Akr1c3 | Rat | gliclazide | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Gliclazide results in decreased activity of AKR1C3 protein | CTD | PMID:26362498 |
Akr1c3 | Rat | glimepiride | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | glimepiride results in decreased activity of AKR1C3 protein | CTD | PMID:26362498 |
Akr1c3 | Rat | glipizide | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Glipizide results in decreased activity of AKR1C3 protein | CTD | PMID:26362498 |
Akr1c3 | Rat | glucose | multiple interactions | ISO | Akr1c18 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of AKR1C18 mRNA | CTD | PMID:37567420 |
Akr1c3 | Rat | glyburide | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Glyburide results in decreased activity of AKR1C3 protein | CTD | PMID:26362498 |
Akr1c3 | Rat | glycidyl methacrylate | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | glycidyl methacrylate results in decreased expression of AKR1C3 protein | CTD | PMID:36641056 |
Akr1c3 | Rat | glycyrrhetinate | affects activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | 18alpha-glycyrrhetinic acid affects the activity of AKR1C3 protein | CTD | PMID:11165023 |
Akr1c3 | Rat | glycyrrhetinate | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Glycyrrhetinic Acid results in decreased activity of AKR1C3 protein | CTD | PMID:12604236 |
Akr1c3 | Rat | glycyrrhetinic acid | affects activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | 18alpha-glycyrrhetinic acid affects the activity of AKR1C3 protein | CTD | PMID:11165023 |
Akr1c3 | Rat | glycyrrhetinic acid | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Glycyrrhetinic Acid results in decreased activity of AKR1C3 protein | CTD | PMID:12604236 |
Akr1c3 | Rat | glyphosate | decreases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | Glyphosate results in decreased expression of AKR1C18 protein | CTD | PMID:37208198 |
Akr1c3 | Rat | gold atom | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Gold results in increased expression of AKR1C3 mRNA | CTD | PMID:29705079 |
Akr1c3 | Rat | gold(0) | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Gold results in increased expression of AKR1C3 mRNA | CTD | PMID:29705079 |
Akr1c3 | Rat | hexane | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | n-hexane results in increased expression of AKR1C3 mRNA | CTD | PMID:20566472 |
Akr1c3 | Rat | hexestrol | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Hexestrol results in decreased activity of AKR1C3 protein | CTD | PMID:12604236 |
Akr1c3 | Rat | hydrogen peroxide | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | 7-hydroxycoumarin inhibits the reaction [AKR1C3 mutant form results in increased susceptibility to Hydrogen Peroxide] more ... | CTD | PMID:21910479 and PMID:22964423 |
Akr1c3 | Rat | hydrogen peroxide | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in increased expression of AKR1C3 protein | CTD | PMID:22964423 |
Akr1c3 | Rat | hydrogen peroxide | increases response to substance | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 mutant form results in increased susceptibility to Hydrogen Peroxide | CTD | PMID:22964423 |
Akr1c3 | Rat | ibuprofen | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Ibuprofen results in decreased activity of AKR1C3 protein | CTD | PMID:19010312 |
Akr1c3 | Rat | indometacin | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of AKR1C3 mRNA more ... | CTD | PMID:17950253 and PMID:28628672 |
Akr1c3 | Rat | indometacin | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Indomethacin analog results in decreased activity of AKR1C3 protein and Indomethacin results in decreased activity of AKR1C3 protein | CTD | PMID:12604236 more ... |
Akr1c3 | Rat | indometacin | affects binding | ISO | AKR1C3 (Homo sapiens) | 6480464 | Indomethacin binds to AKR1C3 protein | CTD | PMID:14996743 |
Akr1c3 | Rat | inulin | multiple interactions | ISO | Akr1c18 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of AKR1C18 mRNA | CTD | PMID:36331819 |
Akr1c3 | Rat | isoeugenol | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | isoeugenol results in increased expression of AKR1C3 mRNA | CTD | PMID:20566472 |
Akr1c3 | Rat | Isoxanthohumol | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | isoxanthohumol results in decreased activity of AKR1C3 protein | CTD | PMID:35065925 |
Akr1c3 | Rat | ivermectin | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of AKR1C3 protein | CTD | PMID:32959892 |
Akr1c3 | Rat | L-methionine | multiple interactions | ISO | Akr1c18 (Mus musculus) | 6480464 | [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of AKR1C18 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of AKR1C18 mRNA | CTD | PMID:20938992 and PMID:29127188 |
Akr1c3 | Rat | lead diacetate | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | lead acetate results in increased expression of AKR1C3 mRNA | CTD | PMID:38568856 |
Akr1c3 | Rat | levonorgestrel | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Levonorgestrel results in decreased activity of AKR1C3 protein | CTD | PMID:21182831 |
Akr1c3 | Rat | lithocholic acid | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Lithocholic Acid results in decreased activity of AKR1C3 protein | CTD | PMID:12604236 and PMID:21851338 |
Akr1c3 | Rat | LY294002 | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cadmium acetate results in increased expression of AKR1C3 protein] and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [panaxytriol results in increased activity of AKR1C3 protein] | CTD | PMID:18826220 and PMID:21787718 |
Akr1c3 | Rat | meclofenamic acid | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Meclofenamic Acid results in decreased activity of AKR1C3 protein | CTD | PMID:19010312 more ... |
Akr1c3 | Rat | Medazepam | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Medazepam results in decreased activity of AKR1C3 protein | CTD | PMID:11995921 and PMID:12604236 |
Akr1c3 | Rat | medroxyprogesterone acetate | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [Medroxyprogesterone Acetate inhibits the reaction [[AKR1C3 protein results in increased metabolism of Prostaglandin D2] which results in increased abundance of Dinoprost]] which results in increased abundance of 15-deoxy-delta(12 more ... | CTD | PMID:19997560 and PMID:23261716 |
Akr1c3 | Rat | medroxyprogesterone acetate | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Medroxyprogesterone Acetate results in decreased activity of AKR1C3 protein | CTD | PMID:12604236 more ... |
Akr1c3 | Rat | mefenamic acid | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Mefenamic Acid analog results in decreased activity of AKR1C3 protein | CTD | PMID:19010312 |
Akr1c3 | Rat | mercury dibromide | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | mercuric bromide results in increased expression of AKR1C3 mRNA | CTD | PMID:26272509 |
Akr1c3 | Rat | mercury dibromide | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1C3 mRNA | CTD | PMID:27188386 |
Akr1c3 | Rat | mercury dichloride | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Mercuric Chloride results in increased expression of AKR1C3 mRNA | CTD | PMID:38568856 |
Akr1c3 | Rat | methapyrilene | increases methylation | ISO | AKR1C3 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of AKR1C3 intron | CTD | PMID:30157460 |
Akr1c3 | Rat | methyl salicylate | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | methyl salicylate results in increased expression of AKR1C3 mRNA | CTD | PMID:20566472 |
Akr1c3 | Rat | methylglyoxal | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Pyruvaldehyde results in increased expression of AKR1C3 mRNA | CTD | PMID:25451587 |
Akr1c3 | Rat | methylmercury chloride | increases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | methylmercuric chloride results in increased expression of AKR1C18 mRNA | CTD | PMID:20061341 |
Akr1c3 | Rat | methylmercury chloride | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of AKR1C3 mRNA | CTD | PMID:28001369 |
Akr1c3 | Rat | methylparaben | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | methylparaben results in decreased expression of AKR1C3 mRNA | CTD | PMID:38568856 |
Akr1c3 | Rat | midostaurin | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | midostaurin results in decreased activity of AKR1C3 protein | CTD | PMID:33025066 |
Akr1c3 | Rat | midostaurin | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | midostaurin inhibits the reaction [AKR1C3 protein results in decreased susceptibility to Daunorubicin] and midostaurin inhibits the reaction [AKR1C3 protein results in increased metabolism of Daunorubicin] | CTD | PMID:33025066 |
Akr1c3 | Rat | N-acetyl-L-cysteine | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [cadmium acetate results in increased expression of AKR1C3 protein] and Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of AKR1C3 mRNA] | CTD | PMID:18829485 and PMID:21787718 |
Akr1c3 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of AKR1C3 mRNA | CTD | PMID:21215737 and PMID:23165153 |
Akr1c3 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [tolfenamic acid inhibits the reaction [AKR1C3 protein results in decreased susceptibility to Cisplatin]] | CTD | PMID:23165153 |
Akr1c3 | Rat | N-nitrosodiethylamine | increases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of AKR1C18 mRNA | CTD | PMID:24535843 |
Akr1c3 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of AKR1C18 mRNA | CTD | PMID:18164116 |
Akr1c3 | Rat | N-nitrosomorpholine | increases expression | EXP | | 6480464 | N-nitrosomorpholine results in increased expression of AKR1C18 protein | CTD | PMID:19716841 |
Akr1c3 | Rat | NAD zwitterion | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein co-treated with NAD] results in increased oxidation of acenaphthene-1-ol more ... | CTD | PMID:25446855 |
Akr1c3 | Rat | NAD(+) | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein co-treated with NAD] results in increased oxidation of acenaphthene-1-ol more ... | CTD | PMID:25446855 |
Akr1c3 | Rat | NADP zwitterion | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein co-treated with NADP] results in increased oxidation of and affects the activity of benzo(a)pyrene 7 more ... | CTD | PMID:14672942 more ... |
Akr1c3 | Rat | NADP(+) | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein co-treated with NADP] results in increased oxidation of and affects the activity of benzo(a)pyrene 7 more ... | CTD | PMID:14672942 more ... |
Akr1c3 | Rat | naphthalenes | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased reduction of and affects the activity of Naphthalenes | CTD | PMID:21910479 |
Akr1c3 | Rat | naproxen | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Naproxen results in decreased activity of AKR1C3 protein | CTD | PMID:19010312 |
Akr1c3 | Rat | nickel atom | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Nickel results in decreased expression of AKR1C3 mRNA | CTD | PMID:23195993 |
Akr1c3 | Rat | nickel sulfate | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of AKR1C3 mRNA | CTD | PMID:20566472 |
Akr1c3 | Rat | nitrazepam | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Nitrazepam results in decreased activity of AKR1C3 protein | CTD | PMID:11995921 |
Akr1c3 | Rat | norethisterone | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Norethindrone results in decreased activity of AKR1C3 protein | CTD | PMID:21182831 |
Akr1c3 | Rat | Nutlin-3 | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of AKR1C3 protein | CTD | PMID:38460933 |
Akr1c3 | Rat | ochratoxin A | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | ochratoxin A results in decreased expression of AKR1C3 mRNA | CTD | PMID:19287073 and PMID:32905824 |
Akr1c3 | Rat | octyl gallate | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | octyl gallate results in decreased activity of AKR1C3 protein | CTD | PMID:27163852 |
Akr1c3 | Rat | oxaliplatin | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | alpha-methylcinnamic acid inhibits the reaction [AKR1C3 protein affects the susceptibility to oxaliplatin] more ... | CTD | PMID:23933386 |
Akr1c3 | Rat | oxaliplatin | affects response to substance | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein affects the susceptibility to oxaliplatin | CTD | PMID:23933386 |
Akr1c3 | Rat | oxcarbazepine | increases reduction | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased reduction of oxcarbazepine | CTD | PMID:25063510 |
Akr1c3 | Rat | oxidopamine | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Oxidopamine results in increased expression of AKR1C3 mRNA and Oxidopamine results in increased expression of AKR1C3 protein | CTD | PMID:33486071 |
Akr1c3 | Rat | oxycodone | decreases expression | EXP | | 6480464 | Oxycodone results in decreased expression of AKR1C3 mRNA | CTD | PMID:23439660 |
Akr1c3 | Rat | ozone | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AKR1C3 mRNA more ... | CTD | PMID:32699268 |
Akr1c3 | Rat | p-chloromercuribenzoic acid | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in increased expression of AKR1C3 mRNA | CTD | PMID:26272509 |
Akr1c3 | Rat | p-chloromercuribenzoic acid | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1C3 mRNA | CTD | PMID:27188386 |
Akr1c3 | Rat | Panaxytriol | increases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | panaxytriol results in increased activity of AKR1C3 protein | CTD | PMID:18826220 |
Akr1c3 | Rat | Panaxytriol | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [panaxytriol results in increased activity of AKR1C3 protein] and Ro 31-8220 inhibits the reaction [panaxytriol results in increased activity of AKR1C3 protein] | CTD | PMID:18826220 |
Akr1c3 | Rat | paracetamol | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of AKR1C3 mRNA | CTD | PMID:21420995 |
Akr1c3 | Rat | paracetamol | multiple interactions | ISO | Akr1c18 (Mus musculus) | 6480464 | PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of AKR1C18 mRNA] | CTD | PMID:29246445 |
Akr1c3 | Rat | paracetamol | increases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | Acetaminophen results in increased expression of AKR1C18 mRNA | CTD | PMID:29246445 |
Akr1c3 | Rat | paracetamol | affects expression | ISO | Akr1c18 (Mus musculus) | 6480464 | Acetaminophen affects the expression of AKR1C18 mRNA | CTD | PMID:17562736 |
Akr1c3 | Rat | paraquat | multiple interactions | ISO | Akr1c18 (Mus musculus) | 6480464 | [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of AKR1C3 mRNA | CTD | PMID:28012437 |
Akr1c3 | Rat | perfluorohexanesulfonic acid | increases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of AKR1C18 mRNA | CTD | PMID:37315490 and PMID:37995155 |
Akr1c3 | Rat | perfluorooctane-1-sulfonic acid | affects expression | ISO | Akr1c18 (Mus musculus) | 6480464 | perfluorooctane sulfonic acid affects the expression of AKR1C18 mRNA and perfluorooctane sulfonic acid affects the expression of AKR1C3 mRNA | CTD | PMID:19429403 |
Akr1c3 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Akr1c18 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of AKR1C18 mRNA | CTD | PMID:36331819 |
Akr1c3 | Rat | perfluorooctanoic acid | affects expression | ISO | Akr1c18 (Mus musculus) | 6480464 | perfluorooctanoic acid affects the expression of AKR1C18 mRNA and perfluorooctanoic acid affects the expression of AKR1C3 mRNA | CTD | PMID:19429403 |
Akr1c3 | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of AKR1C3 mRNA | CTD | PMID:35163327 |
Akr1c3 | Rat | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of AKR1C18 mRNA | CTD | PMID:16221955 and PMID:19162173 |
Akr1c3 | Rat | perfluorooctanoic acid | increases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | perfluorooctanoic acid results in increased expression of AKR1C3 mRNA | CTD | PMID:17681415 |
Akr1c3 | Rat | phenethyl caffeate | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | caffeic acid phenethyl ester results in decreased activity of AKR1C3 protein | CTD | PMID:27163852 |
Akr1c3 | Rat | phenobarbital | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Phenobarbital results in increased expression of AKR1C3 protein | CTD | PMID:35881160 |
Akr1c3 | Rat | phenolphthalein | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | Phenolphthalein inhibits the reaction [AKR1C3 protein affects the susceptibility to oxaliplatin] | CTD | PMID:23933386 |
Akr1c3 | Rat | phenolphthalein | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Phenolphthalein results in decreased activity of AKR1C3 protein | CTD | PMID:12604236 |
Akr1c3 | Rat | phenylmercury acetate | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of AKR1C3 mRNA | CTD | PMID:26272509 |
Akr1c3 | Rat | phenylmercury acetate | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1C3 mRNA | CTD | PMID:27188386 |
Akr1c3 | Rat | phthalaldehyde | affects expression | ISO | Akr1c18 (Mus musculus) | 6480464 | o-Phthalaldehyde affects the expression of AKR1C18 mRNA | CTD | PMID:22302311 |
Akr1c3 | Rat | picoxystrobin | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | picoxystrobin results in increased expression of AKR1C3 mRNA | CTD | PMID:33512557 |
Akr1c3 | Rat | pirinixic acid | multiple interactions | ISO | Akr1c18 (Mus musculus) | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in increased expression of AKR1C18 mRNA] | CTD | PMID:17950772 and PMID:20032461 |
Akr1c3 | Rat | pirinixic acid | increases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of AKR1C18 mRNA | CTD | PMID:17950772 more ... |
Akr1c3 | Rat | potassium chromate | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of AKR1C3 mRNA | CTD | PMID:22079256 |
Akr1c3 | Rat | potassium chromate | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of AKR1C3 mRNA | CTD | PMID:22079256 |
Akr1c3 | Rat | pravastatin | decreases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | Pravastatin results in decreased expression of AKR1C18 mRNA | CTD | PMID:27225895 |
Akr1c3 | Rat | pravastatin | decreases expression | EXP | | 6480464 | Pravastatin results in decreased expression of AKR1C3 mRNA | CTD | PMID:27225895 |
Akr1c3 | Rat | progesterone | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein results in increased metabolism of Progesterone] which results in increased chemical synthesis of 20-alpha-Dihydroprogesterone and [AKR1C3 protein results in increased reduction of Progesterone] which results in increased chemical synthesis of 20-alpha-Dihydroprogesterone | CTD | PMID:19010312 and PMID:20036328 |
Akr1c3 | Rat | progesterone | increases metabolic processing | EXP | | 6480464 | AKR1C18 protein results in increased metabolism of Progesterone | CTD | PMID:8172618 |
Akr1c3 | Rat | progesterone | affects metabolic processing | EXP | | 6480464 | AKR1C18 protein affects the metabolism of Progesterone | CTD | PMID:15261307 |
Akr1c3 | Rat | progesterone | increases metabolic processing | ISO | Akr1c18 (Mus musculus) | 6480464 | AKR1C18 protein results in increased metabolism of Progesterone | CTD | PMID:17122075 |
Akr1c3 | Rat | progesterone | affects metabolic processing | ISO | Akr1c18 (Mus musculus) | 6480464 | AKR1C18 protein affects the metabolism of Progesterone | CTD | PMID:15471942 |
Akr1c3 | Rat | progesterone | affects abundance | ISO | Akr1c18 (Mus musculus) | 6480464 | AKR1C18 protein affects the abundance of Progesterone | CTD | PMID:15471942 |
Akr1c3 | Rat | progesterone | increases reduction | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased reduction of Progesterone | CTD | PMID:20036328 and PMID:25463305 |
Akr1c3 | Rat | progesterone | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Progesterone results in decreased expression of AKR1C3 mRNA | CTD | PMID:23183084 |
Akr1c3 | Rat | progesterone | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Progesterone results in increased expression of AKR1C3 mRNA | CTD | PMID:23183084 |
Akr1c3 | Rat | progesterone | increases metabolic processing | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased metabolism of Progesterone | CTD | PMID:19010312 |
Akr1c3 | Rat | propan-2-ol | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | 2-Propanol results in increased expression of AKR1C3 mRNA | CTD | PMID:20566472 |
Akr1c3 | Rat | prostaglandin D2 | increases metabolic processing | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased metabolism of Prostaglandin D2 | CTD | PMID:19010312 |
Akr1c3 | Rat | prostaglandin D2 | increases reduction | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in increased reduction of Prostaglandin D2 | CTD | PMID:20036328 |
Akr1c3 | Rat | prostaglandin D2 | decreases response to substance | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in decreased susceptibility to Prostaglandin D2 | CTD | PMID:20036328 |
Akr1c3 | Rat | prostaglandin D2 | decreases metabolic processing | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 protein results in decreased metabolism of Prostaglandin D2 | CTD | PMID:20036328 |
Akr1c3 | Rat | prostaglandin D2 | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein results in decreased metabolism of Prostaglandin D2] which results in decreased chemical synthesis of 9-deoxy-delta-9-prostaglandin D2 more ... | CTD | PMID:19997560 and PMID:20036328 |
Akr1c3 | Rat | prostaglandin F2alpha | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein results in increased reduction of Prostaglandin D2] which results in increased chemical synthesis of Dinoprost more ... | CTD | PMID:19997560 and PMID:20036328 |
Akr1c3 | Rat | prostaglandin J2 | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein results in decreased metabolism of Prostaglandin D2] which results in decreased chemical synthesis of 9-deoxy-delta-9-prostaglandin D2 | CTD | PMID:20036328 |
Akr1c3 | Rat | quercetin | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Quercetin results in decreased activity of AKR1C3 protein | CTD | PMID:19007764 |
Akr1c3 | Rat | rac-lactic acid | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of AKR1C3 mRNA | CTD | PMID:20566472 |
Akr1c3 | Rat | resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with Streptozocin] results in decreased expression of AKR1C3 mRNA | CTD | PMID:25905778 |
Akr1c3 | Rat | Ro 31-8220 | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | Ro 31-8220 inhibits the reaction [panaxytriol results in increased activity of AKR1C3 protein] | CTD | PMID:18826220 |
Akr1c3 | Rat | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of AKR1C3 mRNA | CTD | PMID:28374803 |
Akr1c3 | Rat | salicylic acid | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Salicylic Acid results in decreased activity of AKR1C3 protein | CTD | PMID:19010312 |
Akr1c3 | Rat | SB 431542 | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 |
Akr1c3 | Rat | silibinin | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Silybin results in decreased activity of AKR1C3 protein | CTD | PMID:19007764 |
Akr1c3 | Rat | silicon dioxide | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of AKR1C3 mRNA | CTD | PMID:25895662 |
Akr1c3 | Rat | silicon dioxide | decreases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of AKR1C18 mRNA | CTD | PMID:29341224 |
Akr1c3 | Rat | silicon dioxide | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Silicon Dioxide results in increased expression of AKR1C3 mRNA | CTD | PMID:25351596 |
Akr1c3 | Rat | silicon dioxide | increases secretion | ISO | AKR1C3 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased secretion of AKR1C3 protein | CTD | PMID:25895662 |
Akr1c3 | Rat | simvastatin | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Simvastatin results in decreased expression of AKR1C3 mRNA | CTD | PMID:18192897 |
Akr1c3 | Rat | sodium arsenate | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of AKR1C3 mRNA | CTD | PMID:32525701 |
Akr1c3 | Rat | sodium arsenite | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of AKR1C3 mRNA and sodium arsenite results in increased expression of AKR1C3 protein | CTD | PMID:12727804 more ... |
Akr1c3 | Rat | sodium arsenite | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of arsenite] which results in increased expression of AKR1C3 mRNA | CTD | PMID:32076005 |
Akr1c3 | Rat | sodium arsenite | multiple interactions | ISO | Akr1c18 (Mus musculus) | 6480464 | sodium arsenite promotes the reaction [Diethylstilbestrol results in increased expression of AKR1C3 mRNA] | CTD | PMID:19665456 |
Akr1c3 | Rat | sodium arsenite | affects expression | ISO | Akr1c18 (Mus musculus) | 6480464 | sodium arsenite affects the expression of AKR1C18 mRNA | CTD | PMID:16507464 |
Akr1c3 | Rat | sodium arsenite | decreases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of AKR1C18 mRNA | CTD | PMID:17350061 |
Akr1c3 | Rat | sodium dichromate | decreases expression | EXP | | 6480464 | sodium bichromate results in decreased expression of AKR1C3 mRNA | CTD | PMID:25993096 |
Akr1c3 | Rat | sodium dodecyl sulfate | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Sodium Dodecyl Sulfate results in increased expression of AKR1C3 mRNA | CTD | PMID:20566472 |
Akr1c3 | Rat | sodium dodecyl sulfate | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Sodium Dodecyl Sulfate results in decreased expression of AKR1C3 mRNA | CTD | PMID:31734321 |
Akr1c3 | Rat | sodium dodecyl sulfate | decreases expression | EXP | | 6480464 | Sodium Dodecyl Sulfate results in decreased expression of AKR1C18 mRNA | CTD | PMID:12815608 |
Akr1c3 | Rat | streptozocin | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with Streptozocin] results in decreased expression of AKR1C3 mRNA | CTD | PMID:25905778 |
Akr1c3 | Rat | streptozocin | multiple interactions | ISO | Akr1c18 (Mus musculus) | 6480464 | [Streptozocin co-treated with Dietary Fats] results in increased expression of AKR1C18 mRNA | CTD | PMID:29127188 |
Akr1c3 | Rat | sulforaphane | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | sulforaphane results in increased expression of AKR1C3 mRNA and sulforaphane results in increased expression of AKR1C3 protein | CTD | PMID:24383545 and PMID:31746589 |
Akr1c3 | Rat | sulindac | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Sulindac results in decreased activity of AKR1C3 protein | CTD | PMID:19010312 |
Akr1c3 | Rat | sulpiride | decreases expression | EXP | | 6480464 | Sulpiride results in decreased expression of AKR1C3 mRNA | CTD | PMID:21427058 |
Akr1c3 | Rat | superoxide | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein results in increased reduction of 9 more ... | CTD | PMID:19442656 and PMID:21910479 |
Akr1c3 | Rat | testosterone | increases abundance | ISO | AKR1C3 (Homo sapiens) | 6480464 | AKR1C3 promoter SNP results in increased abundance of Testosterone | CTD | PMID:16263811 |
Akr1c3 | Rat | testosterone | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [AKR1C3 protein results in increased metabolism of Androstenedione] which results in increased chemical synthesis of Testosterone and [AKR1C3 protein results in increased reduction of Androstenedione] which results in increased chemical synthesis of Testosterone | CTD | PMID:19010312 and PMID:20036328 |
Akr1c3 | Rat | testosterone enanthate | affects expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | testosterone enanthate affects the expression of AKR1C3 mRNA | CTD | PMID:17440010 |
Akr1c3 | Rat | tetrachloromethane | increases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of AKR1C18 mRNA | CTD | PMID:27339419 |
Akr1c3 | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of AKR1C3 mRNA | CTD | PMID:31150632 |
Akr1c3 | Rat | tetraphene | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | benz(a)anthracene results in increased expression of AKR1C3 mRNA | CTD | PMID:22236718 |
Akr1c3 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of AKR1C18 mRNA and Thioacetamide results in decreased expression of AKR1C3 mRNA | CTD | PMID:23411599 and PMID:34492290 |
Akr1c3 | Rat | titanium dioxide | affects expression | ISO | Akr1c18 (Mus musculus) | 6480464 | titanium dioxide affects the expression of AKR1C18 mRNA | CTD | PMID:23557971 |
Akr1c3 | Rat | titanium dioxide | multiple interactions | ISO | Akr1c18 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of AKR1C18 mRNA | CTD | PMID:29950665 |
Akr1c3 | Rat | titanium dioxide | increases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of AKR1C18 mRNA | CTD | PMID:23131501 |
Akr1c3 | Rat | tolcapone | decreases expression | EXP | | 6480464 | tolcapone results in decreased expression of AKR1C3 mRNA | CTD | PMID:24136188 |
Akr1c3 | Rat | tolfenamic acid | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | tolfenamic acid results in decreased activity of AKR1C3 protein | CTD | PMID:21187079 and PMID:23165153 |
Akr1c3 | Rat | tolfenamic acid | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [tolfenamic acid results in decreased activity of AKR1C3 protein] which results in increased chemical synthesis of farnesoic acid more ... | CTD | PMID:21187079 and PMID:23165153 |
Akr1c3 | Rat | trans-isoeugenol | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | isoeugenol results in increased expression of AKR1C3 mRNA | CTD | PMID:20566472 |
Akr1c3 | Rat | trichloroethene | increases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | Trichloroethylene results in increased expression of AKR1C18 mRNA | CTD | PMID:25549359 |
Akr1c3 | Rat | trichostatin A | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of AKR1C3 mRNA | CTD | PMID:24935251 and PMID:26705709 |
Akr1c3 | Rat | triclosan | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of AKR1C3 mRNA | CTD | PMID:30510588 |
Akr1c3 | Rat | trimellitic anhydride | increases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of AKR1C18 mRNA | CTD | PMID:19042947 |
Akr1c3 | Rat | trimellitic anhydride | affects expression | ISO | Akr1c18 (Mus musculus) | 6480464 | trimellitic anhydride affects the expression of AKR1C18 mRNA | CTD | PMID:22302311 |
Akr1c3 | Rat | triphenyl phosphate | affects expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of AKR1C3 mRNA | CTD | PMID:37042841 |
Akr1c3 | Rat | troglitazone | increases expression | ISO | Akr1c18 (Mus musculus) | 6480464 | troglitazone results in increased expression of AKR1C3 mRNA | CTD | PMID:28973697 |
Akr1c3 | Rat | umbelliferone | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | 7-hydroxycoumarin results in increased expression of AKR1C3 mRNA and 7-hydroxycoumarin results in increased expression of AKR1C3 protein | CTD | PMID:22964423 and PMID:28263721 |
Akr1c3 | Rat | umbelliferone | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | 7-hydroxycoumarin inhibits the reaction [AKR1C3 mutant form results in increased susceptibility to 4-hydroxy-2-nonenal] and 7-hydroxycoumarin inhibits the reaction [AKR1C3 mutant form results in increased susceptibility to Hydrogen Peroxide] | CTD | PMID:22964423 |
Akr1c3 | Rat | uranium atom | affects expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Uranium affects the expression of AKR1C3 mRNA | CTD | PMID:15672453 |
Akr1c3 | Rat | urethane | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Urethane results in decreased expression of AKR1C3 mRNA | CTD | PMID:28818685 |
Akr1c3 | Rat | ursodeoxycholic acid | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | Ursodeoxycholic Acid results in decreased activity of AKR1C3 protein | CTD | PMID:12604236 |
Akr1c3 | Rat | valproic acid | decreases methylation | ISO | AKR1C3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of AKR1C3 gene | CTD | PMID:29154799 |
Akr1c3 | Rat | valproic acid | multiple interactions | ISO | AKR1C3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1C3 mRNA | CTD | PMID:27188386 |
Akr1c3 | Rat | valproic acid | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of AKR1C3 mRNA | CTD | PMID:23179753 more ... |
Akr1c3 | Rat | valproic acid | affects expression | ISO | Akr1c18 (Mus musculus) | 6480464 | Valproic Acid affects the expression of AKR1C18 mRNA | CTD | PMID:17292431 |
Akr1c3 | Rat | valproic acid | affects expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of AKR1C3 mRNA | CTD | PMID:25979313 |
Akr1c3 | Rat | vorinostat | increases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | vorinostat results in increased expression of AKR1C3 mRNA | CTD | PMID:18769122 |
Akr1c3 | Rat | vorinostat | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of AKR1C3 mRNA | CTD | PMID:18769122 |
Akr1c3 | Rat | zaragozic acid A | increases expression | EXP | | 6480464 | squalestatin 1 results in increased expression of AKR1C3 mRNA | CTD | PMID:27225895 |
Akr1c3 | Rat | zaragozic acid A | affects expression | ISO | Akr1c18 (Mus musculus) | 6480464 | squalestatin 1 affects the expression of AKR1C18 mRNA | CTD | PMID:27225895 |
Akr1c3 | Rat | zinc atom | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of AKR1C3 mRNA | CTD | PMID:22171008 |
Akr1c3 | Rat | zinc(0) | decreases expression | ISO | AKR1C3 (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of AKR1C3 mRNA | CTD | PMID:22171008 |
Akr1c3 | Rat | zomepirac | decreases activity | ISO | AKR1C3 (Homo sapiens) | 6480464 | zomepirac results in decreased activity of AKR1C3 protein | CTD | PMID:19010312 |